244 related articles for article (PubMed ID: 25554605)
1. Evolution of primary care referrals to urology. Impact of a protocol on prostate disease and continuing education.
Sopeña-Sutil R; Tejido-Sánchez A; Galván-Ortiz de Urbina M; Guerrero-Ramos F; García-Álvarez G; Passas-Martínez JB
Actas Urol Esp; 2015 Jun; 39(5):296-302. PubMed ID: 25554605
[TBL] [Abstract][Full Text] [Related]
2. Analysis of referrals after a synergic work between Primary Care and Urology. Impact of joint protocol implementation and a continuing education program in our healthcare area.
García-Rojo E; Medina-Polo J; Sopeña-Sutil R; Guerrero-Ramos F; García-Gómez B; Aguilar-Gisbert L; García-Álvarez G; Azcutia-Gómez MR; Gómez-Martín F; Molero-García JM; Pereda-Arregui E; Vargas-Machuca Cabañero MC; Villacampa-Aubá F; Tejido Sánchez Á
Actas Urol Esp (Engl Ed); 2019 May; 43(4):176-181. PubMed ID: 30824338
[TBL] [Abstract][Full Text] [Related]
3. Implementing an action protocol on prostatic disease in primary care and impact on referrals to urology.
Tejido-Sánchez A; Villacampa-Aubá F; Molero-García JM; García-Alvarez G; Passas-Martínez J; Díaz-González R
Arch Esp Urol; 2012 Oct; 65(8):737-44. PubMed ID: 23117681
[TBL] [Abstract][Full Text] [Related]
4. [Use of prostatic specific antigen in primary care (PSA)].
Panach-Navarrete J; Gironés-Montagud A; Sánchez-Cano E; Doménech-Pérez C; Martínez-Jabaloyas JM
Semergen; 2017 Apr; 43(3):189-195. PubMed ID: 27344583
[TBL] [Abstract][Full Text] [Related]
5. [Consensus document on the management and follow-up of the male with lower urinary tract symptoms secondary to benign prostate hyperplasia].
Brenes Bermúdez FJ; Brotons Muntó F; Castiñeiras Fernández J; Cozar Olmo JM; Fernández-Pro Ledesma A; Martín Jiménez JA; Martínez-Berganza Asensio ML; Miñana López B; Molero García JM
Semergen; 2016; 42(8):547-556. PubMed ID: 28314432
[TBL] [Abstract][Full Text] [Related]
6. [Urology clinics referral Patterns after initiation of a Primary Care BPH-LUTS protocol.].
Martínez Ruiz J; Carrión López P; Giménez Bachs JM; Pastor Navarro H; Martínez Sanchiz C; Fernández Anguita PJ; Moreillo Vicente L; Salinas Sánchez AS
Arch Esp Urol; 2020 Sep; 73(7):573-581. PubMed ID: 32886072
[TBL] [Abstract][Full Text] [Related]
7. [Referral criteria for benign prostatic hyperplasia in primary care.Sociedad Española de Médicos de Atención Primaria, Sociedad Española de Medicina General, Sociedad Española de Medicina de Familia y Comunitaria, Asociación Española de Urología].
Castiñeiras Fernández J; Cozar Olmo JM; Fernández-Pro A; Martín JA; Brenes Bermúdez FJ; Naval Pulido E; Molero JM; Pérez Morales D; ; ; ;
Actas Urol Esp; 2010 Jan; 34(1):24-34. PubMed ID: 20223130
[TBL] [Abstract][Full Text] [Related]
8. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians.
Collins MM; Barry MJ; Bin L; Roberts RG; Oesterling JE; Fowler FJ
J Gen Intern Med; 1997 Apr; 12(4):224-9. PubMed ID: 9127226
[TBL] [Abstract][Full Text] [Related]
10. Use of Prostate-Specific Antigen Testing Is in the Eye of the Beholder.
Aaronson DS; Redberg RF
JAMA Intern Med; 2016 Apr; 176(4):547-8. PubMed ID: 26856746
[No Abstract] [Full Text] [Related]
11. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
[TBL] [Abstract][Full Text] [Related]
12. Do men with lower urinary tract symptoms have an increased risk of advanced prostate cancer?
Østerø Í Jákupsstovu J; Brodersen J
BMJ; 2018 May; 361():k1202. PubMed ID: 29724877
[No Abstract] [Full Text] [Related]
13. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
Tikkinen KAO; Dahm P; Lytvyn L; Heen AF; Vernooij RWM; Siemieniuk RAC; Wheeler R; Vaughan B; Fobuzi AC; Blanker MH; Junod N; Sommer J; Stirnemann J; Yoshimura M; Auer R; MacDonald H; Guyatt G; Vandvik PO; Agoritsas T
BMJ; 2018 Sep; 362():k3581. PubMed ID: 30185545
[No Abstract] [Full Text] [Related]
14. Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations.
Zavaski ME; Meyer CP; Sammon JD; Hanske J; Gupta S; Sun M; Trinh QD
JAMA Intern Med; 2016 Apr; 176(4):546-7. PubMed ID: 26857148
[No Abstract] [Full Text] [Related]
15. A practical primary care approach to lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH-LUTS).
Rosenberg MT; Witt ES; Miner M; Barkin J
Can J Urol; 2014 Jun; 21 Suppl 2():12-24. PubMed ID: 24978629
[TBL] [Abstract][Full Text] [Related]
16. Referral rates in Swiss primary care with a special emphasis on reasons for encounter.
Tandjung R; Hanhart A; Bärtschi F; Keller R; Steinhauer A; Rosemann T; Senn O
Swiss Med Wkly; 2015; 145():w14244. PubMed ID: 26709751
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
18. Re: variation among primary care physicians in prostate-specific antigen screening of older men.
Penson DF
J Urol; 2014 May; 191(5):1291-2. PubMed ID: 24745493
[No Abstract] [Full Text] [Related]
19. Primary care physician referral patterns in Ontario, Canada: a descriptive analysis of self-reported referral data.
Liddy C; Arbab-Tafti S; Moroz I; Keely E
BMC Fam Pract; 2017 Aug; 18(1):81. PubMed ID: 28830380
[TBL] [Abstract][Full Text] [Related]
20. Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.
Pickles K; Carter SM; Rychetnik L
BMJ Open; 2015 Mar; 5(3):e006367. PubMed ID: 25783420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
